During the past decade, Peak Clinical Trials conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Peak Clinical Trials" are "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Symptomatic Neurogenic Orthostatic Hypotension" (1 trials). Many other conditions were trialed in "Peak Clinical Trials" in a lesser frequency.

Most popular intervention types in "Peak Clinical Trials" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Droxidopa capsules" (1 trials), "Macitentan" (1 trials), "Placebo" (1 trials) and "Placebo capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peak Clinical Trials" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Peak Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Peak Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peak Clinical Trials, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".